CN101270137A - 神经节苷脂的提取、纯化方法 - Google Patents
神经节苷脂的提取、纯化方法 Download PDFInfo
- Publication number
- CN101270137A CN101270137A CNA2007100554426A CN200710055442A CN101270137A CN 101270137 A CN101270137 A CN 101270137A CN A2007100554426 A CNA2007100554426 A CN A2007100554426A CN 200710055442 A CN200710055442 A CN 200710055442A CN 101270137 A CN101270137 A CN 101270137A
- Authority
- CN
- China
- Prior art keywords
- sialo
- sphingolipids
- ganglioside
- scf
- neutral lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000605 extraction Methods 0.000 title abstract description 14
- 150000002270 gangliosides Chemical class 0.000 title abstract description 10
- 238000000746 purification Methods 0.000 title abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 20
- 241001465754 Metazoa Species 0.000 claims abstract description 16
- 239000012535 impurity Substances 0.000 claims abstract description 16
- 150000002632 lipids Chemical class 0.000 claims abstract description 15
- 230000007935 neutral effect Effects 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 13
- 238000000926 separation method Methods 0.000 claims abstract description 13
- 210000004556 brain Anatomy 0.000 claims abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- 238000005377 adsorption chromatography Methods 0.000 claims abstract description 3
- 150000003408 sphingolipids Chemical class 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 7
- 230000002490 cerebral effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 2
- 235000011089 carbon dioxide Nutrition 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- 229910018503 SF6 Inorganic materials 0.000 claims 1
- 239000001272 nitrous oxide Substances 0.000 claims 1
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 claims 1
- 229960000909 sulfur hexafluoride Drugs 0.000 claims 1
- 210000001835 viscera Anatomy 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000005013 brain tissue Anatomy 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 9
- 230000006837 decompression Effects 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000003838 Sialyltransferases Human genes 0.000 description 1
- 108090000141 Sialyltransferases Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002461 excitatory amino acid Effects 0.000 description 1
- 239000003257 excitatory amino acid Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 230000004898 mitochondrial function Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100554426A CN101270137B (zh) | 2007-03-22 | 2007-03-22 | 神经节苷脂的提取、纯化方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100554426A CN101270137B (zh) | 2007-03-22 | 2007-03-22 | 神经节苷脂的提取、纯化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101270137A true CN101270137A (zh) | 2008-09-24 |
CN101270137B CN101270137B (zh) | 2011-04-20 |
Family
ID=40004387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100554426A Expired - Fee Related CN101270137B (zh) | 2007-03-22 | 2007-03-22 | 神经节苷脂的提取、纯化方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101270137B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251651A (zh) * | 2013-05-20 | 2013-08-21 | 吉林省中韩动物科学研究院 | 一种动物神经节苷脂与脑苷脂提取方法与其应用 |
CN109320566A (zh) * | 2018-08-14 | 2019-02-12 | 四川兴杰象药业有限公司 | 一种从猪脑髓中提取神经节苷脂的分离纯化制备方法 |
CN109394789A (zh) * | 2018-09-06 | 2019-03-01 | 四川鼎润元生物科技有限公司 | 一种脑神经组织提取方法 |
CN109464464A (zh) * | 2018-09-06 | 2019-03-15 | 四川鼎润元生物科技有限公司 | 一种改善脑神经组织的功能性口服液及其制备方法 |
CN110592164A (zh) * | 2019-09-23 | 2019-12-20 | 东北师范大学 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
CN111499671A (zh) * | 2020-04-14 | 2020-08-07 | 内蒙古自治区中医药研究所 | 羊脑中几种不同类型神经节苷脂的提取制备方法 |
-
2007
- 2007-03-22 CN CN2007100554426A patent/CN101270137B/zh not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103251651A (zh) * | 2013-05-20 | 2013-08-21 | 吉林省中韩动物科学研究院 | 一种动物神经节苷脂与脑苷脂提取方法与其应用 |
CN109320566A (zh) * | 2018-08-14 | 2019-02-12 | 四川兴杰象药业有限公司 | 一种从猪脑髓中提取神经节苷脂的分离纯化制备方法 |
CN109320566B (zh) * | 2018-08-14 | 2022-03-15 | 四川兴杰象药业有限公司 | 一种从猪脑髓中提取神经节苷脂的分离纯化制备方法 |
CN109394789A (zh) * | 2018-09-06 | 2019-03-01 | 四川鼎润元生物科技有限公司 | 一种脑神经组织提取方法 |
CN109464464A (zh) * | 2018-09-06 | 2019-03-15 | 四川鼎润元生物科技有限公司 | 一种改善脑神经组织的功能性口服液及其制备方法 |
CN109464464B (zh) * | 2018-09-06 | 2021-10-12 | 四川鼎润元生物科技有限公司 | 一种改善脑神经组织的功能性口服液及其制备方法 |
CN110592164A (zh) * | 2019-09-23 | 2019-12-20 | 东北师范大学 | 一种单唾液酸四己糖神经节苷脂的制备方法 |
CN111499671A (zh) * | 2020-04-14 | 2020-08-07 | 内蒙古自治区中医药研究所 | 羊脑中几种不同类型神经节苷脂的提取制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101270137B (zh) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101270137B (zh) | 神经节苷脂的提取、纯化方法 | |
CN110304994B (zh) | 一种从工业大麻中提取高纯度大麻二酚的方法 | |
CN102161689B (zh) | 一种从油茶饼粕中提取茶皂素的方法 | |
CN102276682B (zh) | 一种从枇杷叶中提取熊果酸的方法 | |
CN104120037A (zh) | 一种茉莉花精油的提取方法 | |
CN113896754B (zh) | 一种从黄芩中提取纯化黄芩苷的工业化生产方法 | |
CN102146083B (zh) | 一种千金藤素的分离提取方法 | |
CN105713732B (zh) | 一种八角茴香油的提取方法 | |
CN101575279B (zh) | 超临界萃取核桃青皮废渣中胡桃醌方法 | |
CN110818585A (zh) | 一种从九香虫中同时制备五种多巴胺类化合物的分离方法 | |
CN113527087B (zh) | 一种高纯度阿魏酸的制备方法 | |
CN102228515A (zh) | 一种分离和富集莲子心总黄酮和总生物碱的方法 | |
CN102973732A (zh) | 大孔树脂富集纯化广东紫珠中总苯乙醇苷的方法 | |
KR101170471B1 (ko) | 천연식물로부터 유효성분을 추출/농축하여 엽록소를 얻는 제조방법 | |
CN107892688A (zh) | 一种从黄柏中制备盐酸小檗碱的方法 | |
Mlyuka et al. | Strategic applications and the challenges of subcritical water extraction technology in food industries | |
CN1806831B (zh) | 一种治疗银屑病的药物及其制备方法 | |
CN101638404A (zh) | 高纯度丹酚酸b、制备方法及应用 | |
CN104292212A (zh) | 一种利用电渗析法分离纯化烟碱的方法 | |
CN1114389C (zh) | 中草药有效成分的提取工艺及生产设备 | |
CN101259151A (zh) | 不含生物碱和氰苷的西番莲总黄酮和总皂苷的制备工艺 | |
CN110408404A (zh) | 油茶壳浸提液及其制备方法和应用 | |
CN110643433A (zh) | 一种石斛花精油的提取方法 | |
CN116515559B (zh) | 一种基于亚临界低温萃取工艺提取沉香精油的方法 | |
CN102429965A (zh) | 一种丹皮中各活性成分的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JILIN YINGLIAN BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: JILIN YINGLIAN BIOTECHNOLOGY CO., LTD. Effective date: 20111109 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111109 Address after: 132300 No. 1188, Renmin West Road, Panshi Economic Development Zone, Jilin Patentee after: JILIN YINGLIAN BIOPHARMACEUTICAL Co.,Ltd. Address before: 132300 No. 1188, Renmin West Road, Panshi Economic Development Zone, Jilin Patentee before: CHANGCHUN YINGLIAN BIOTECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 |
|
CF01 | Termination of patent right due to non-payment of annual fee |